Table 3.
The effect of compound 1 on blood glucose levels of diabetic rats.
| No. | Treatment | Blood glucose levels (mean ± SD, mg/dL) | ||
|---|---|---|---|---|
| Pretreatment blood | Diabetic blood | Posttreatment blood | ||
| 1 | B0 | 105.00 ± 3.94 | 396.00 ± 3.67 | 412.20 ± 7.76 |
| B1 | 88.20 ± 4.17 | 339.20 ± 12.49 | 98.00 ± 1.67 | |
| B2 | 103.40 ± 6.80 | 377.00 ± 25.33 | 171.00 ± 3.81 | |
| B3 | 87.00 ± 4.42 | 357.40 ± 28.87 | 138.00 ± 1.87 | |
| B4 | 93.80 ± 11.12 | 379.40 ± 21.33 | 108.40 ± 3.21 | |
|
| ||||
| 2 | ANOVA table | F (DFn, DFd) | p value | |
| Interaction | F (8, 40) = 146.2 | <0.0001 | ||
| Dose (biflavonoid and control) | F (2, 40) = 2985 | <0.0001 | ||
| Blood glucose level | F (4, 20) = 239 | <0.0001 | ||
|
| ||||
| 3 | Tukey's post hoc test | p value | Significant? | |
| B0 versus B1 | <0.0001 | Yes | ||
| B1 versus B2 | <0.0001 | Yes | ||
| B1 versus B3 | 0.0049 | Yes | ||
| B1 versus B4 | 0.0055 | Yes | ||
Different letters indicate significant differences between the groups (p < 0.05). Tukey's post hoc test following the two-way ANOVA. B0: the negative control, B1: the positive control, B2: the compound 1 given at a dose of 6 μg/kg body weight, B3: the compound 1 given at a dose of 7 μg/kg body weight, B4: the compound 1 given at a dose of 8 μg/kg body weight.